한국어
Quantus

Protec

053610 · KOSDAQ
₩60,000+3.27%
2026-09-04 close

Protec last closed at ₩60,000 (+3.27%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
Market Leader RS 90 · top 10%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

A+
Overall: 반도체 4/125 · top 2%
Factor composite · relative position in sector

PER 30.44 · PBR 2.17 — own-history percentile 1/100 · 1/100

Open self-history band
PER1/100
PBR1/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend per share chart2002: 24원20022003: 24원2004: No dividend paid2005: No dividend paid20052006: 53원2007: No dividend paid2008: 40원2009: 81원2010: 97원20102011: 145원2012: 168원2013: 140원2014: 75원2015: 149원20152016: 140원2017: 140원2018: 187원2019: 280원2020: 400원20202021: 300원2022: 400원2023: 500원2024: 400원2025: 400원400원2025
Annual dividend (per share · split-adjusted) · as of 2025
Consistency
A-
Growth
C+
Yield
D
Safety
A-
Reference indicatorView observed cut rates

Paid 18 consecutive years · Raised 0 consecutive years · Yield 0.67% (based on 2025 payment of 400원) · 3-year growth +0.0%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 10.83
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
10.83
Beneish M-Score
-2.24

No statistical flag

Sloan accrual
0.69%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

6/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score6/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 49% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

반도체

This stock is in 반도체: revenue rank 60 of 125, share 0%.

60 / 1250%revenue share

Who dominates this industry?

  1. 1삼성전자75.4%
  2. 2SK하이닉스16.6%
  3. 3SK스퀘어0.5%
  4. 4동진쎄미켐0.4%
  5. 5하나마이크론0.3%
  6. 6프로텍0%

Concentration

ConcentratedCR3 92.5%
HHI 5,966125 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
16.34
Direction
확대
Level
넓음
Years
6

Value lens

P90/P10
10.1
Median P/B
1.85
Level
넓음
n
123

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
7.3%
Interest coverage
14.8x
Return on equity (ROE)
7.1%

Operating margin −5pp

Severe margin pressure
Interest coverageBase 14.8x adverse case 4.6x
Return on equity (ROE)Base 7.1% adverse case 1%

Revenue −15%

Tolerable
Interest coverageBase 14.8x adverse case 12.6x
Return on equity (ROE)Base 7.1% adverse case 3.2%

Interest rate +2pp

Tolerable
Interest coverageBase 14.8x adverse case 5.4x
Return on equity (ROE)Base 7.1% adverse case 3.3%

Interest coverage limit

Current margin 6.8pp

Interest coverage limit at an operating margin of 0.5%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-19

Suppliers disclosed by the company in its 2026-03-19 annual report.

Suppliers without disclosed amount

DISPENSERBOARD

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 최승환37.28%2026-05-07 · 증감 +7.38%p
  • 브이아이피자산운용7.82%2026-08-10 · 증감 +1.27%p

Recent filings

Protec's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Protec
What technical signals does Protec (053610) have?
Protec current technical signals: no active technical signal.
Is Protec a cup-and-handle pattern?
No. Protec has no valid cup-and-handle signal right now.
What are Protec's financials and valuation?
Protec's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy